A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

Autor: Hainsworth, John D., Cebotaru, Cristina L., Kanarev, Vladimir, Ciuleanu, Tudor E., Damyanov, Danail, Stella, Phillip, Ganchev, Hristo, Pover, Gillian, Morris, Clive, Tzekova, Valentina
Zdroj: In Journal of Thoracic Oncology October 2010 5(10):1630-1636
Databáze: ScienceDirect